Cargando…
Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study
To evaluate the effectiveness of targeted therapy on preventing or treating COVID‐19, in this study, we want to share our experience about 14 patients (nine women, five men; average age, 59 years) who were treated with targeted therapy due to their underlying malignant disorders in our center.
Autores principales: | Khodadadi, Kasra, Moghimi, Minoosh, Mansouri, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576967/ https://www.ncbi.nlm.nih.gov/pubmed/36267821 http://dx.doi.org/10.1002/ccr3.6392 |
Ejemplares similares
-
Clinical patterns of endothelial damage and thrombotic events in two patients with COVID‐19: A case report
por: Moghimi, Minoosh, et al.
Publicado: (2021) -
Correlation between CSF biomarkers and COVID-19 meningoencephalitis: A case series
por: Moghimi, Minoosh, et al.
Publicado: (2020) -
Dermatomyositis following Biosimilar Trastuzumab in a Breast Cancer Patient: A Case Report
por: Moghimi, Minoosh, et al.
Publicado: (2021) -
Red cell distribution width, a predictive factor in immunocompromised patients with COVID-19: A comparison retrospective study between cancer and kidney transplant patients
por: Moghimi, Minoosh, et al.
Publicado: (2022) -
Stent thrombosis during COVID‐19 pandemic: A case series
por: Montaseri, Mohammad, et al.
Publicado: (2022)